Range
19.51 - 21.14
Vol / Avg.
36.5K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
1B
Payout Ratio
-
Open
19.83
P/E
-
EPS
-0.21
Shares
48.3M
Outstanding
48.3M
Total Float
21.6M
Sector: Health Care.Industry: Biotechnology
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-12-08
REV
Q2 2021Est.ActualSurprise
EPS-0.190-3.170 -2.9800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Nuvalent Questions & Anwsers

Q

How do I buy Nuvalent (NUVL) stock?

A

You can purchase shares of Nuvalent (NASDAQ: NUVL) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Nuvalent (NUVL) stock?

A

The latest price target for Nuvalent (NASDAQ: NUVL) was reported by Cowen & Co. on August 23, 2021. The analyst firm set a price target for 0.00 expecting NUVL to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Nuvalent (NUVL)?

A

The stock price for Nuvalent (NASDAQ: NUVL) is $21.1 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

Does Nuvalent (NUVL) pay a dividend?

A

There are no upcoming dividends for Nuvalent.

Q

When is Nuvalent (NASDAQ:NUVL) reporting earnings?

A

Nuvalent’s $Q3 earnings are confirmed for after-market on $December 8, 2021.

Q

Is Nuvalent (NUVL) going to split?

A

There is no upcoming split for Nuvalent.

Q

What sector and industry does Nuvalent (NUVL) operate in?

A

Nuvalent is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.